Pharmaceutical Quality Management Systems Industry Expected to Value $3.97 Billion by 2030


Posted June 27, 2024 by komal123

Meticulous Research®—a leading global market research company, published a research report titled, ‘Pharmaceutical Quality Management Systems Market
 
Meticulous Research®—a leading global market research company, published a research report titled, ‘Pharmaceutical Quality Management Systems Market by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO) - Global Forecast to 2030.’
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=5398?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=27-06-2024
Meticulous Research® has unveiled its latest report, forecasting that the global pharmaceutical quality management systems market will achieve a valuation of $3.97 billion by 2030, with a robust compound annual growth rate (CAGR) of 15.6%. Key drivers of this growth include rising drug manufacturing costs, the increasing necessity for regulatory compliance, rapid industry expansion, and the advantages provided by software-based quality management systems. However, the high costs associated with deploying these systems remain a significant challenge.
Opportunities and Challenges
The market is poised for significant opportunities driven by the expanding generic drugs and biopharmaceuticals markets and the increasing adoption of platform-as-a-service solutions by pharmaceutical companies. Conversely, security concerns related to cloud-based deployments present a major challenge.
Key Industry Players
Prominent players in the pharmaceutical quality management systems market include:
ANTARES VISION SpA (Italy) AssurX Inc. (U.S.) AXSource Consulting Inc. (U.S.)Körber AG (Germany) Compliance Quest, Inc. (U.S.) Dassault Systèmes SE (France)EtQ Management Consultants Inc. (U.S.Honeywell International Inc. (U.S.) Ideagen PLC (U.K.)IQVIA HOLDINGS INC. (U.S.)Logic Gate Inc. (U.S.) MasterControl, Inc. (U.S.)
Market Segmentation
The global market is segmented by:
Solution Type :Non-conformance/Deviation Management CAPA Management Audit Management Risk & Compliance Management Suppliers & Materials Management Inspection Management Document Management Change Management Training Management Other Solution Types Deployment Mode :Cloud/Web-Based On-Premise
End User:
Pharmaceutical and Biotechnology Companies Contract Development Manufacturing Organizations (CDMOs)Contract Research Organizations (CROs)Research Laboratories
Solution Type Insights
In 2023, the non-conformance/deviation management segment is expected to hold the largest market share. The importance of managing non-conformance and deviations is emphasized by industry standards such as ISO 9001:2015. Implementing these controls helps organizations identify and address quality issues early, minimizing operational disruptions. Regulatory importance further drives this segment's dominance.
End User Insights
Pharmaceutical and biotechnology companies are anticipated to dominate the market, driven by the demand for new drugs and therapies, extensive R&D activities, increased funding and investments, and government support for biopharmaceutical manufacturing and research
Geographic Insights
This research encompasses North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Ireland, Belgium, Netherlands, and the Rest of Europe), Asia-Pacific (China, Japan, India, Malaysia, Philippines, Vietnam, Singapore, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa. Asia-Pacific is projected to experience the highest CAGR during the forecast period, driven by advancements in healthcare infrastructure, R&D sector development, a large population base, and government initiatives to enhance healthcare facilities.
Buy Now@ https://www.meticulousresearch.com/Checkout/13952044?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=27-06-2024
About Meticulous Research®:
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By komal
Country India
Categories Health
Last Updated June 27, 2024